New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Tuberculosis (TB) remains one of humanity’s oldest and most persistent health challenges. Despite significant medical advances, this infectious disease continues to affect millions globally, with ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Once a disease that brought patients flocking to New Mexico by the thousands, tuberculosis remains a top global killer.

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

Jiawan, D., Bansie, R., Chan, M., Thakoer, I. and Gopie, F.A. (2025) Necrotizing Sarcoid Granulomatosis with Concurrent ...